Literature DB >> 8482286

Isolated defect of peroxisomal beta-oxidation in a 16-year-old patient.

R Santer1, A Claviez, H D Oldigs, J Schaub, R B Schutgens, R J Wanders.   

Abstract

We describe a 16-year-old boy suffering from psychomotor retardation, sensorineuronal hearing impairment, peripheral neuropathy, hepatosplenomegaly, short stature and delayed puberty. Postnatally, muscular hypotonia, mild facial dysmorphism and delayed fontanelle closure had been noticed. At the time of our examination, adrenal cortical function was normal. Biochemical analysis revealed accumulation of very long (> C22) chain fatty acids in plasma and fibroblasts. Furthermore, elevated levels of intermediates of bile acid synthesis and phytanic acid were detectable. These findings are consistent with a defect in the peroxisomal beta-oxidation system. A generalised defect of peroxisomal function was excluded by normal plasmalogen levels in erythrocytes and normal plasmalogen de novo synthesis in fibroblasts. Immunoblotting of the peroxisomal beta-oxidation enzymes gave normal results suggesting retained immunoreactivity but catalytic inactivity of one of the enzymes involved, probably either the trifunctional protein or the peroxisomal ketothiolase. This case markedly differs clinically from the few published reports on isolated deficiencies of peroxisomal beta-oxidation. Among the patients with comparable biochemical findings, this is the first report of survival into adolescence.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482286     DOI: 10.1007/bf01956749

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  A bifunctional protein with deficient enzymic activity: identification of a new peroxisomal disorder using novel methods to measure the peroxisomal beta-oxidation enzyme activities.

Authors:  R J Wanders; C W van Roermund; A Schelen; R B Schutgens; J M Tager; J B Stephenson; P T Clayton
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 2.  Peroxisomal disorders: clinical characterization.

Authors:  L Monnens; H Heymans
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

3.  Dietary effects on serum-phytanic-acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis.

Authors:  L Eldjarn; K Try; O Stokke; A W Munthe-Kaas; S Refsum; D Steinberg; J Avigan; C Mize
Journal:  Lancet       Date:  1966-03-26       Impact factor: 79.321

4.  Mitochondrial oxidation of phytanic acid in human and monkey liver: implication that Refsum's disease is not a peroxisomal disorder.

Authors:  P A Watkins; S J Mihalik
Journal:  Biochem Biophys Res Commun       Date:  1990-03-16       Impact factor: 3.575

5.  Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors.

Authors:  G Schrakamp; C G Schalkwijk; R B Schutgens; R J Wanders; J M Tager; H van den Bosch
Journal:  J Lipid Res       Date:  1988-03       Impact factor: 5.922

6.  Zellweger-like syndrome with detectable hepatic peroxisomes: a variant form of peroxisomal disorder.

Authors:  Y Suzuki; N Shimozawa; T Orii; N Igarashi; N Kono; A Matsui; Y Inoue; S Yokota; T Hashimoto
Journal:  J Pediatr       Date:  1988-11       Impact factor: 4.406

7.  Peroxisomal bifunctional enzyme deficiency.

Authors:  P A Watkins; W W Chen; C J Harris; G Hoefler; S Hoefler; D C Blake; A Balfe; R I Kelley; A B Moser; M E Beard
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

8.  Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.

Authors:  H W Moser; A B Moser; N Kawamura; J Murphy; K Suzuki; H Schaumburg; Y Kishimoto
Journal:  Ann Neurol       Date:  1980-06       Impact factor: 10.422

9.  A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy).

Authors:  B T Poll-The; F Roels; H Ogier; J Scotto; J Vamecq; R B Schutgens; R J Wanders; C W van Roermund; M J van Wijland; A W Schram
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

10.  A milder variant of Zellweger syndrome.

Authors:  P G Barth; R B Schutgens; J A Bakkeren; K P Dingemans; H S Heymans; A C Douwes; J M van der Klei-van Moorsel
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

View more
  4 in total

1.  Measurement of dihydroxyacetone-phosphate acyltransferase (DHAPAT) in chorionic villous samples, blood cells and cultured cells.

Authors:  R J Wanders; R Ofman; G J Romeijn; R B Schutgens; P A Mooijer; C Dekker; H van den Bosch
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

2.  Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts.

Authors:  R J Wanders; S Denis; J P Ruiter; R B Schutgens; C W van Roermund; B S Jacobs
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.

Authors:  B C Paton; P C Sharp; D I Crane; A Poulos
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

4.  Mitochondrial neurogastrointestinal encephalomyopathy: Clinical and biochemical impact of allogeneic stem cell transplantation in a Greek patient with one novel TYMP mutation.

Authors:  A Paisiou; M Rogalidou; R Pons; E Ioannidou; K Dimakou; A Papadopoulou; F M Vaz; G Vessalas; S M I Goorden; J Roelofsen; A Zoetekouw; M M Nieman; E Dimitriou; M Moraitou; I Peristeri; H Michelakakis; A B P van Kuilenburg
Journal:  Mol Genet Metab Rep       Date:  2021-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.